MedPath

The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
Hypoglycemia Unawareness
Interventions
Behavioral: Lay down comfortably
Behavioral: High intensity exercise
Registration Number
NCT02308293
Lead Sponsor
Radboud University Medical Center
Brief Summary

Iatrogenic hypoglycemia is the most frequent acute complication of insulin therapy in people with type 1 diabetes (T1DM). Recurrent hypoglycemic events initiate a process of habituation, characterized by suppression of hypoglycemic symptoms, eventually leading to hypoglycemia unawareness, which creates a particularly high risk of severe hypoglycemia. Recent evidence suggest a pivotal role for (brain) lactate in the pathogenesis of hypoglycemia unawareness. Indeed, exogenous lactate administration may preserve brain function and attenuate counterregulatory responses to and symptomatic awareness of hypoglycemia. It is unknown whether endogenous elevation of plasma lactate produces the same effects and whether such effects differ between patients with T1DM with and without hypoglycemia unawareness and healthy controls.

Objective: To investigate the effect of elevated levels of endogenous lactate on brain lactate accumulation and on counterregulatory responses to, symptomatic awareness of and cognitive function during hypoglycemia in patients with T1DM with and without hypoglycemia unawareness and normal controls.

Hypothesis: The investigators hypothesize first that endogenous lactate, when raised through high intensity exercise, preserves neuronal metabolism during subsequent hypoglycemia, which in turn will attenuate counterregulatory hormone responses, appearance of symptoms and deterioration of cognitive function. Second, the investigators posit that these effects will be augmented in patients with hypoglycemia unawareness compared to healthy subjects and T1DM patients with normal awareness as a consequence of greater transport capacity of lactate into the brain.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Lay down comfortablyLay down comfortablyAs a control conditions, subjects wil lay down comfortably and rest
High intensity exerciseHigh intensity exerciseSubjects will preform a high intensity training exercise (3\* 30 seconds all out sprint on a cycle ergometer) to raise plasma lactate levels
Primary Outcome Measures
NameTimeMethod
Plasma level of adrenaline in response to hypoglycemia (Adrenaline, measured in arterial plasma)during 60 m of hypoglycemia
Secondary Outcome Measures
NameTimeMethod
Plasma lactate levels (Lactate levels measured in arterial plasma)During 60 min hypoglycemia

Lactate levels measured in arterial plasma

Glucose infusion rate (Amount of glucose 20% necessary to maintain plasma glucose at steady state values)During 60 min hypoglycemia

Amount of glucose 20% necessary to maintain plasma glucose at steady state values

Plasma levels of inflammatory markers (levels of cytokines)During 60 min hypoglycemia

levels of cytokines

Brain perfusion measured with ASL-MRIDuring 60 min hypoglycemia

Brain perfusion measured with ASL-MRI

Plasma levels of other counter-regulatory hormones (Levels of counter-regulatory hormones measured in arterial plasma)During 60 min hypoglycemia

Levels of counter-regulatory hormones measured in arterial plasma

Cognitive functioning, as measured by cognitive testsDuring 60 min hypoglycemia

Cognitive test will be: Dutch State Trait Anxiety Inventory, Digit Span, Stroop color word test, word fluency test, trail making test and Pasat

Brain lactate accumulation measured with 1H-MRSDuring 60 min of hypoglycemia

Brain lactate levels measured with 1H-MRS

Trial Locations

Locations (1)

Radboud umc

🇳🇱

Nijmegen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath